SPAR Group Inc., a global supplier of retail merchandising and other marketing services, today announced its 2011 fourth quarter and year-end financial results. For the three months ended December 31, 2011, SPAR reported revenues of $23.6 million, a 26 percent … Continue reading →

Today, Recon Technology, which has built a strong reputation within China’s burgeoning oil field services industry as a 10-year veteran, non-state owned, broad spectrum provider of ingenious software and field service equipment engineered to improve efficiency/automation, reported debut of the … Continue reading →

Today, Avanir Pharmaceuticals announced that the company has appointed Rohan Palekar to the position of senior vice president and chief commercial officer. In his new role, Mr. Palekar will lead all of the company’s commercial activities. “I am excited to … Continue reading →

On Friday, Tucows announced the reinstatement of the stock buyback program that the company had previously put on suspension. The suspension was enacted when Tucow undertook its most recent Dutch Auction Tender, which was completed on January 20, 2012. The … Continue reading →

Cross Border Resources reported large year-over-year increases in sales as well as oil and gas production in 2011. The company benefited from increased development of its properties and continuing high prices for crude oil. Cross Border Resources reported sales of … Continue reading →

Before you understand the power of social media, it’s important to recognize and respect the sweeping reach of the Internet and its applications. According to U.S. Census Bureau, most recent 2012 numbers estimate that more than 7 billion people currently … Continue reading →

Cytori Therapeutics is developing cell therapies based on autologous adipose-derived regenerative cells (ADRCs) to treat cardiovascular disease and repair soft tissue defects. The company believes ADRCs improve blood flow, moderate the immune response, and keep at-risk tissues from dying. The … Continue reading →

Earlier this month, when TONIX Pharmaceuticals, developer of drugs for treating central nervous system disorders, announced the closing of the final tranche of a private placement financing deal resulting in total net proceeds of $5.9 million, the company indicated that … Continue reading →